Table 4.
Vif/Vpr and Gag sequences containing G-to-A mutations that resulted in Stop/Start codon mutations, other mutations, or no mutations.
| Sample | Total Sequences with Stop/Start Codon Mutations (%) |
Total Sequences w/ Other Mutations (%) |
Total Sequences w/ No Mutations (%) |
| Vif/Vpr | |||
| DNA (Round 2 +3) |
83 (59.7%) | 30 (21.6%) | 26 (18.2%) |
| Cellular Viral RNA (Round 2+3) |
24 (22.2%) | 22 (20.4%) | 62 (57.4%) |
| Virion RNA (Round 2+3) |
13 (10.2%) | 16 (12.6%) | 98 (77.2%) |
| Gag | |||
| DNA (Round 2) |
17 (70.8%) | 2 (8.3%) | 5 (20.8%) |
| Cellular Viral RNA (Round 2) |
26 (22.4%) | 24 (20.7%) | 66 (56.9%) |
| Virion RNA (Round 2) |
6 (6.3%) | 12 (12.5%) | 78 (81.3%) |